Keruo Wang

机构：Tianjin Medical University General Hospital, Second Hospital of Tianjin Medical University, Tianjin Medical University

发表论文 26 篇 · 总被引 139 次 · h-index 6

代表论文

• Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer (2023 · Cell Death and Disease · 被引 39)
• Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma (2021 · Frontiers in Molecular Biosciences · 被引 29)
• Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer (2024 · Oncogene · 被引 11)
• CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model (2024 · BMC Cancer · 被引 11)
• Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development (2022 · Frontiers in Oncology · 被引 10)
• Tumor margin irregularity degree is an important preoperative predictor of adverse pathology for clinical T1/2 renal cell carcinoma and the construction of predictive model (2024 · World Journal of Urology · 被引 8)